Aspira Women’s Health Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Aspira Women’s Health Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-03-31 was $916.00K.
- Aspira Women’s Health Inc. stock issued during period, value, conversion of convertible securities for fiscal 2025 was $916.00K.
- Aspira Women’s Health Inc. stock issued during period, value, conversion of convertible securities for fiscal 2017 was $3.58M.
- Aspira Women’s Health Inc. stock issued during period, value, conversion of convertible securities for fiscal 2010 was $458.00K.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2025-12-31 | $916.00K 10-K · filed 2026-04-01 | |
| 2025-03-31 | $916.00K 10-Q · filed 2026-08-14 | |
| 2017-12-31 | $3.58M 10-K · filed 2018-03-13 | |
| 2010-12-31 | $458.00K 10-K · filed 2012-03-27 |